[조사 보고서] 세계의 유전자 합성 (연구용) 시장 (2023-2030) : 방법별 (고체상, 칩 기반), 연구 단계별 (전임상, 임상), 용도별, 서비스별, 최종 용도별

■ 영문 제목 : Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV123 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 180 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 유전자 합성 (연구용) 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면 글로벌 유전자 합성 (연구용) 시장 규모는 2030년까지 51. 4억 달러에 달할 것으로 예상되며 2023년부터 2030년까지 16. 1%의 CAGR로 성장할 것으로 예상됩니다. 시장 성장의 주요 요인은 연구 개발 활동의 증가, 시장 경쟁의 심화, 합성 생물학 분야의 발전 증가입니다. 유전자 합성과 관련된 다양한 응용 분야도 시장 성장의 원동력이 될 것으로 예상됩니다. 유전자 합성과 관련된 방법은 고유한 장점을 가지고 있어 널리 사용될 수 있습니다. 예를 들어, 유전자 합성과 관련된 고체상 합성 기술은 용액상 시약을 과도하게 사용함으로써 합성 반응을 가속화할 수 있습니다.

또한, 각 단계 후 정제 과정을 거치지 않고도 수행할 수 있습니다. 또한, 이 방법은 합성 공정의 효율을 높이는 데에도 도움이 됩니다. 이 때문에 애질런트 테크놀로지(Agilent Technology), 블루헤론 바이오테크(Blue Heron Biotech) 등 여러 기업이 유전자 합성에 고상합성법을 사용하고 있습니다. 합성 생물학 및 유전자 합성에 대한 연구 개발 활동에 대한 관심이 증가함에 따라 지난 몇 년 동안 시장 성장이 크게 촉진되었습니다. 또한, 합성 생물학 및 유전자 합성과 관련된 연구 활동을 수행하는 연구 기관 및 대학이 설립되고 있는 것도 시장 성장을 지원할 것으로 예상됩니다. 예를 들어, 코펜하겐 대학의 합성생물학 센터는 덴마크에서 합성생물학을 연구하는 주요 학과 중 하나입니다.

또한, 유전자 합성 시장의 선도기업인 Integrated DNA Technologies(IDT)는 2023년 2월에 영향력 있는 연구와 기술 개발을 위해 업계 파트너와 연구자들을 연결하는 Collab Network를 도입했습니다. 이러한 요인들은 향후 몇 년 동안 유전자 합성의 성장을 강화할 것으로 예상됩니다. 또한 업계 경쟁이 치열해지면서 유전자 합성 서비스가 강화될 것으로 보입니다. 주요 기업들은 비용 효율적인 서비스를 제공하고 업계에서 입지를 강화하기 위해 다양한 접근법을 시행하고 있습니다. 이러한 시장 참여자들은 시장의 미래 기회에 초점을 맞추고 있습니다. 예를 들어, 유전자 합성 회사인 Evonetix의 팀은 로스 앤젤레스에서 열린 Synthetic Biology: Engineering, Evolution & Design (SEED) 2023 컨퍼런스에 참석하여 합성 생물학의 진보를 이해했습니다.

유전자 합성 (연구용) 시장 보고서 하이라이트

- 고체상 합성 부문은 이 방법이 제공하는 다양한 장점과 이점과 많은 플레이어의 높은 채택으로 인해 2022년 가장 높은 매출 점유율을 기록했습니다.

- 항체 DNA 합성 서비스 부문은 유전자 합성의 높은 채택률과 항체 개발에서의 효과로 인해 2022년 가장 큰 수익 점유율을 차지했습니다.

- 유전자 및 세포 치료 개발 응용 분야는 2022년에 가장 큰 수익 점유율을 차지하며 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 유전자 및 세포치료제 개발 활동의 증가가 세그먼트 성장을 촉진하고 있습니다.

- 임상 연구 단계 부문은 2022년에 가장 큰 매출 점유율을 차지하고 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 정부의 지원 정책과 유전자 치료제 개발에서 유전자 합성의 중요한 역할이 세그먼트 성장을 촉진할 것으로 예상됩니다.

- 학술 및 정부 연구 기관 최종 사용 부문은 2022년 가장 큰 점유율을 차지할 것으로 예상됩니다. 합성 생물학 연구에 대한 관심과 집중도가 높아지면서 이 부문의 성장을 촉진할 것으로 예상됩니다.

- 북미는 다양한 선도 기업이 존재하기 때문에 2022년 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 아시아 태평양 지역은 치료제 개발을 위한 연구 활동의 증가로 인해 예측 기간 동안 가장 빠른 CAGR을 기록할 것으로 예상됩니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변수/동향/범위
Chapter 4. 세계의 유전자 합성 (연구용) 시장 : 방법별 예측 및 동향 분석
Chapter 5. 세계의 유전자 합성 (연구용) 시장 : 서비스별 예측 및 동향 분석
Chapter 6. 세계의 유전자 합성 (연구용) 시장 : 용도별 예측 및 동향 분석
Chapter 7. 세계의 유전자 합성 (연구용) 시장 : 연구 단계별 예측 및 동향 분석
Chapter 8. 세계의 유전자 합성 (연구용) 시장 : 최종 용도별 예측 및 동향 분석
Chapter 9. 세계의 유전자 합성 (연구용) 시장 : 지역별 예측 및 동향 분석
Chapter 10. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Market definitions
1.2. Information Procurement
1.2.1. Market formulation & data visualization
1.2.2. Data validation & publishing
1.3. Research Assumptions
1.4. Research Methodology
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.1.1. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. Global Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Obective 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Rising investment in synthetic biology market
3.3.1.2. Advent of enzymatic DNA synthesis process
3.3.1.3. Technological advancements in the DNA synthesis platforms
3.3.1.4. Declining price of DNA synthesis & sequencing
3.3.2. Market Restraint Analysis
3.3.2.1. Lack of skilled professionals
3.3.2.2. Misuse of gene synthesis
3.4. Industry Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.2. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
3.4.3. COVID-19 Impact Analysis
Chapter 4. Gene Synthesis (Research Use) Market: Method Estimates & Trend Analysis
4.1. Global Gene Synthesis (Research Use) Market: Method Movement Analysis
4.2. Solid-phase Synthesis
4.2.1. Solid Phase Synthesis Market, 2018 – 2030 (USD Million)
4.3. Chip-based Synthesis
4.3.1. Chip Based Synthesis Market, 2018 – 2030 (USD Million)
4.4. PCR-based Enzyme Synthesis
4.4.1. PCR based Enzyme Synthesis Market, 2018 – 2030 (USD Million)
Chapter 5. Gene Synthesis (Research Use) Market: Service Estimates & Trend Analysis
5.1. Global Gene Synthesis (Research Use) Market: Services Movement Analysis
5.2. Antibody DNA Synthesis
5.2.1. Antibody DNA Synthesis Market, 2018 – 2030 (USD Million)
5.3. Viral DNA Synthesis
5.3.1. Viral DNA Synthesis Market, 2018 – 2030 (USD Million)
5.4. Others
5.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Gene Synthesis (Research Use) Market: Application Estimates & Trend Analysis
6.1. Global Gene Synthesis (Research Use) Market: Application Movement Analysis
6.2. Gene & Cell Therapy Development
6.2.1. Gene & Cell Therapy Development Market, 2018 – 2030 (USD Million)
6.3. Vaccine Development
6.3.1. Vaccine Development Market, 2018 – 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Gene Synthesis (Research Use) Market: Research Phase Estimates & Trend Analysis
7.1. Global Gene Synthesis (Research Use) Market: Research Phase Movement Analysis
7.2. Preclinical
7.2.1. Preclinical Market, 2018 – 2030 (USD Million)
7.3. Clinical
7.3.1. Clinical Market, 2018 – 2030 (USD Million)
Chapter 8. Gene Synthesis (Research Use) Market: End-use Estimates & Trend Analysis
8.1. Global Gene Synthesis (Research Use) Market: End-use Movement Analysis
8.2. Biopharmaceutical & Pharmaceutical Companies
8.2.1. Biopharmaceutical & Pharmaceutical Companies Market, 2018 – 2030 (USD Million)
8.3. Academic & Government Research Institutes
8.3.1. Academic & Government Research Institutes Market, 2018 – 2030 (USD Million)
8.4. Contract Research Organizations
8.4.1. Contract Research Organizations Market, 2018 – 2030 (USD Million)
Chapter 9. Gene Synthesis (Research Use) Market: Region Estimates & Trend Analysis
9.1. Gene Synthesis (Research Use) Market: Region Outlook
9.2. North America
9.2.1. North America gene synthesis (research use) market estimates and forecast, 2018 – 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. U.S. gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Canada gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3. Europe
9.3.1. Europe gene synthesis (research use) market estimates and forecast, 2018 – 2030 (USD Million)
9.3.2. Germany
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Germany gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.3. France
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. France gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.4. UK
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. UK gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Italy gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Spain gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Denmark gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Sweden gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Norway gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.10. The Netherlands
9.3.10.1. Key Country Dynamics
9.3.10.2. Target Disease Prevalence
9.3.10.3. Competitive Scenario
9.3.10.4. Regulatory Framework
9.3.10.5. The Netherlands gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.3.11. Switzerland
9.3.11.1. Key Country Dynamics
9.3.11.2. Target Disease Prevalence
9.3.11.3. Competitive Scenario
9.3.11.4. Regulatory Framework
9.3.11.5. Switzerland gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific gene synthesis (research use) market estimates and forecast, 2018 – 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Japan gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. China gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. India gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Australia gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. South Korea gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Thailand gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America gene synthesis (research use) market Estimates And Forecast, 2018 – 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Brazil gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Mexico gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Target Disease Prevalence
9.5.4.3. Competitive Scenario
9.5.4.4. Regulatory Framework
9.5.4.5. Argentina gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6. Middle East & Africa
9.6.1. Middle East & Africa gene synthesis (research use) market Estimates And Forecast, 2018 – 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Saudi Arabia gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6.3. South Africa
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. South Africa gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. UAE gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Kuwait gene synthesis market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Share Analysis, 2022
10.4. Company Profiles/Listing
10.4.1. GenScript
10.4.1.1. Overview
10.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.1.3. Method Benchmarking
10.4.1.4. Strategic Initiatives
10.4.2. Azenta, Inc. (GENEWIZ)
10.4.2.1. Overview
10.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.2.3. Method Benchmarking
10.4.2.4. Strategic Initiatives
10.4.3. Boster Biological Technology
10.4.3.1. Overview
10.4.3.2. Method Benchmarking
10.4.3.3. Strategic Initiatives
10.4.4. Twist Bioscience
10.4.4.1. Overview
10.4.4.2. Method Benchmarking
10.4.4.3. Strategic Initiatives
10.4.5. ProteoGenix, Inc
10.4.5.1. Overview
10.4.5.2. Method Benchmarking
10.4.5.3. Strategic Initiatives
10.4.6. Biomatik.
10.4.6.1. Overview
10.4.6.2. Method Benchmarking
10.4.6.3. Strategic Initiatives
10.4.7. ProMab Biotechnologies, Inc.
10.4.7.1. Overview
10.4.7.2. Method Benchmarking
10.4.7.3. Strategic Initiatives
10.4.8. Thermo Fisher Scientific, Inc
10.4.8.1. Overview
10.4.8.2. Method Benchmarking
10.4.8.3. Strategic Initiatives
10.4.9. Integrated DNA Technologies, Inc. (Danaher)
10.4.9.1. Overview
10.4.9.2. Method Benchmarking
10.4.9.3. Strategic Initiatives
10.4.10. OriGene Technologies, Inc.
10.4.10.1. Overview
10.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
10.4.10.3. Method Benchmarking
10.4.10.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 4 Global gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 5 Global gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 6 Global gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 7 Global gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 8 North America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 9 North America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 10 North America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 11 North America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 12 North America synthesis market by Application, 2018 - 2030 (USD Million)
Table 13 U.S. gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 14 U.S. gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 15 U.S. gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 16 U.S. gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 17 U.S. gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 18 Canada gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 19 Canada gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 20 Canada gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 21 Canada gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 22 Canada gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 23 Europe gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 24 Europe gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 25 Europe gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 26 Europe gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 27 Europe gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 28 UK gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 29 UK gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 30 UK gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 31 UK gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 32 UK gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 33 Germany gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 34 Germany gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 35 Germany gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 36 Germany gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 37 Germany gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 38 France gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 39 France gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 40 France gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 41 France gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 42 France gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 43 Italy gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 44 Italy gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 45 Italy gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 46 Italy gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 47 Italy gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 48 Spain gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 49 Spain gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 50 Spain gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 51 Spain gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 52 Spain gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 53 Denmark gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 54 Denmark gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 55 Denmark gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 56 Denmark gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 57 Denmark gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 58 Sweden gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 59 Sweden gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 60 Sweden gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 61 Sweden gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 62 Sweden gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 63 Norway gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 64 Norway gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 65 Norway gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 66 Norway gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 67 Norway gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 68 The Netherlands gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 69 The Netherlands gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 70 The Netherlands gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 71 The Netherlands gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 72 The Netherlands gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 73 Switzerland gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 74 Switzerland gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 75 Switzerland gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 76 Switzerland gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 77 Switzerland gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 78 Asia Pacific gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 79 Asia Pacific gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 80 Asia Pacific gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 81 Asia Pacific gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 82 Asia Pacific gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 83 Japan gene synthesis (research use) market by End- Use, 2018 - 2030 (USD Million)
Table 84 Japan gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 85 Japan gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 86 Japan gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 87 Japan gene synthesis (research use) market by Research Use, 2018 - 2030 (USD Million)
Table 88 China gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 89 China gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 90 China gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 91 China gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 92 China gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 93 India gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 94 India gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 95 India gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 96 India gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 97 India gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 98 Australia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 99 Australia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 100 Australia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 101 Australia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 102 Australia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 103 Thailand gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 104 Thailand gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 105 Thailand gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 106 Thailand gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 107 Thailand gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 108 South Korea gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 109 South Korea gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 110 South Korea gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 111 South Korea gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 112 South Korea synthesis market by Research Phase, 2018 - 2030 (USD Million)
Table 113 Latin America gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 114 Latin America gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 115 Latin America gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 116 Latin America gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 117 Latin America gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 118 Brazil gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 119 Brazil gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 120 Brazil gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 121 Brazil gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 122 Brazil gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 123 Mexico gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 124 Mexico gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 125 Mexico gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 126 Mexico gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 127 Mexico gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 128 Argentina gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 129 Argentina gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 130 Argentina gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 131 Argentina gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 132 Argentina gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 133 Middle East & Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 134 Middle East & Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 135 Middle East & Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 136 Middle East & Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 137 Middle East & Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 143 South Africa gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 144 South Africa gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 145 South Africa gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 146 South Africa gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 147 South Africa gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 148 UAE gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 149 UAE gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 150 UAE gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 151 UAE gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 152 UAE gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 153 Kuwait gene synthesis (research use) market by Method, 2018 - 2030 (USD Million)
Table 154 Kuwait gene synthesis (research use) market by Services, 2018 - 2030 (USD Million)
Table 155 Kuwait gene synthesis (research use) market by End Use, 2018 - 2030 (USD Million)
Table 156 Kuwait gene synthesis (research use) market by Application, 2018 - 2030 (USD Million)
Table 157 Kuwait gene synthesis (research use) market by Research Phase, 2018 - 2030 (USD Million)
Table 158 Participant’s overview
Table 159 Financial performance
Table 160 Key companies undergoing expansions
Table 161 Key companies undergoing acquisitions
Table 162 Key companies undergoing collaborations
Table 163 Key companies launching new products/services
Table 164 Key companies undergoing partnerships
Table 165 Key companies undertaking other strategies

※본 조사보고서 [세계의 유전자 합성 (연구용) 시장 (2023-2030) : 방법별 (고체상, 칩 기반), 연구 단계별 (전임상, 임상), 용도별, 서비스별, 최종 용도별] (코드 : GRV23NOV123) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 유전자 합성 (연구용) 시장 (2023-2030) : 방법별 (고체상, 칩 기반), 연구 단계별 (전임상, 임상), 용도별, 서비스별, 최종 용도별] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 치과용 컴프레서 시장 (2023-2030) : 종류별 (치과용 윤활식 컴프레서, 치과용 오일 프리 컴프레서), 기술별, 용도별, 지역별
GRV23MA107 / Grand View Research / 2023년 1월 / Grand View Research사는 글로벌 치과용 컴프레서 시장 규모가 2023년부터 2030년 사이에 연평균 5.0% 성장하여, 2030년에는 530.5백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 글로벌 치과용 컴프레서 시장을 조사대상으로 하여,...Dental Compressors Market Growth & Trends The global dental compressors market size is expected to reach USD 530.5 million by 2030, registering a CAGR of 5.0% from 2023 to 2030, according to a new report by Grand View Research, Inc. Every dentist's office needs an air compressor for dental procedure...

세계의 소변 검사 시장 (2023-2030) : 제품별 (기기, 소모품), 용도별 (질병 검사, 임신 및 불임 검사), 최종 용도별 (병원, 재택 의료), 지역별
GRV24JNU010 / Grand View Research / 2023년 12월 / 글로벌 소변 검사 시장의 성장 및 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 소변 검사 시장 규모는 2023년부터 2030년까지 연평균 4.7%의 성장률을 보이며 2030년에는 30.7억 달러에 달할 것으로...1. 조사 방법 및 범위 2. 개요 3. 세계의 소변 검사 시장 변수, 동향, 범위 4. 세계의 소변 검사 시장 규모 : 제품별 예측 및 동향 분석 5. 세계의 소변 검사 시장 규모 : 용도별 예측 및 동향 분석 6. 세계의 소변 검사 시장 규모 : 최종 용도별 예측 및...

세계의 히알루론산 시장 (2024-2030) : 용도별 (피부 필러, 골관절염, 안과, 방광 요로 역류증), 지역별
GRV24JNU088 / Grand View Research / 2023년 12월 / 글로벌 히알루론산 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 히알루론산 시장 규모는 2024년부터 2030년까지 7.7%의 CAGR을 기록하며 2030년까지 167.5억 달러에 달할 것으로 예상됩니다. 화학 물질에 대한...1. 조사 방법 및 범위 2. 개요 3. 세계의 히알루론산 시장 변수, 동향 및 범위 4. 세계의 히알루론산 시장 규모 : 용도별 추정 및 동향 분석 5. 세계의 히알루론산 시장 규모 : 지역별 추정 및 동향 분석 6 . 경쟁 현황...

세계의 코 부목 시장 2024-2030 : 유형별 (가단성, 기도), 재료별 (플라스틱 부목, 금속 부목), 용도별, 메커니즘별, 최종 용도별, 지역별
GRV24MAY082 / Grand View Research / 2024년 4월 / 글로벌 코 부목 시장의 성장 및 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 코 부목 시장 규모는 2030년까지 21억 달러에 달할 것으로 예상되며, 2024년부터 2030년까지 연평균 4. 5%의...1. 조사 방법 및 범위 2. 개요 3. 세계의 코 부목 시장 변수, 동향 및 범위 4. 세계의 코 부목 시장 유형별 예측 및 동향 분석 5. 세계의 코 부목 시장 재료별 유형별 예측 및 동향 분석 6. 세계의 코 부목 시장 용도별 예측 및 동향 분석 7. 세계의 코...

세계의 아시네토박테르 폐렴 치료제 시장 2024-2030 : 약물 종류별 (자쿠듀로, 폴리믹신, 세팔로스포린, 카바페넴), 투여 경로별 (경구, 비경구), 지역별
GRV24MAY096 / Grand View Research / 2024년 4월 / 글로벌 아시네토박테르 폐렴 치료제 시장의 성장과 동향 Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 아시네토박테르 폐렴 치료제 시장 규모는 2024년부터 2030년까지 6. 70%의 CAGR을 기록하며 2030년까지 4억 7,096만 달러에...1. 조사 방법 및 범위 2. 개요 3. 시장 변수, 동향 및 범위 4. 세계의 아시네토박테르 폐렴 치료제 시장 약물 종류별 예측 및 동향 분석 5. 세계의 아시네토박테르 폐렴 치료제 시장 투여 경로별 예측 및 동향 분석 6. 세계의 아시네토박테르 폐렴 치료제 시장 지역별 예측 및 동향 분석 7. 경쟁...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!